Literature DB >> 15240613

Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes.

Maria Yaneva1, Helen Mosnier-Pudar, Marie-Annick Dugué, Sophie Grabar, Yvonne Fulla, Xavier Bertagna.   

Abstract

We assessed the value of midnight salivary cortisol for the initial diagnosis of Cushing's syndrome. Sixty-three patients with various causes of Cushing's syndrome (37 with Cushing's disease, 17 with adrenal Cushing's syndrome, and nine with ectopic ACTH syndrome) and 54 control subjects with simple obesity were studied. All patients with Cushing's syndrome excreted more than 90 microg urinary free cortisol (UFC)/d (248 nmol/d), and all controls excreted less than 90 microg/d UFC. All patients with Cushing's syndrome had a midnight salivary cortisol concentration above 2.0 ng/ml (5.52 nmol/liter), whereas only three controls did so [2.0 ng/ml (5.52 nmol/liter); 2.05 ng/ml (5.66 nmol/liter); and 3.6 ng/ml (9.96 nmol/liter)]. This cut-off provides a sensitivity of 100% and a specificity of 96%. In patients with Cushing's syndrome, midnight salivary cortisol concentrations were correlated with UFC collected over the same period of time (0800-0800 h). Salivary cortisol measurements taken every 4 h showed a typical lack of circadian variation. The daily measurement of midnight salivary cortisol concentrations for 2 wk or more in five other out-patients (with obvious Cushing's disease, subclinical adrenal Cushing's syndrome, suspected Cushing's syndrome, pituitary incidentaloma, and prolactinoma) demonstrated the clinical utility of this factor. Measuring midnight salivary cortisol is an easy and noninvasive means of diagnosing hypercortisolism. Its diagnostic accuracy is identical to, if not better than, that of previously described gold standards.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240613     DOI: 10.1210/jc.2003-031790

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  24 in total

1.  Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing's syndrome using an automated immunoassay system.

Authors:  C A Carrasco; M García; M Goycoolea; J Cerda; J Bertherat; O Padilla; D Meza; N Wohllk; T Quiroga
Journal:  Endocrine       Date:  2012-01-24       Impact factor: 3.633

2.  Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test.

Authors:  Chiara Dall'Asta; Laura Barbetta; Luigi Bonavina; Paolo Beck-Peccoz; Bruno Ambrosi
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

3.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

Review 4.  Measuring stress in wildlife: techniques for quantifying glucocorticoids.

Authors:  Michael J Sheriff; Ben Dantzer; Brendan Delehanty; Rupert Palme; Rudy Boonstra
Journal:  Oecologia       Date:  2011-02-23       Impact factor: 3.225

5.  Cyclical Cushing's: how best to catch the ups and downs.

Authors:  Malik Asif Humayun; Tanya Hart; Tristan Richardson
Journal:  BMJ Case Rep       Date:  2017-07-13

6.  Concordance of the late night salivary cortisol in patients with Cushing's syndrome and elevated urine-free cortisol.

Authors:  Suhail A R Doi; Justin Clark; Anthony W Russell
Journal:  Endocrine       Date:  2012-12-14       Impact factor: 3.633

7.  Salivary concentration of progesterone and cortisol significantly differs across individuals after correcting for blood hormone values.

Authors:  Shoko Konishi; Eleanor Brindle; Amanda Guyton; Kathleen A O'Connor
Journal:  Am J Phys Anthropol       Date:  2012-07-24       Impact factor: 2.868

Review 8.  Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis-Prognostic and Predictive Factors.

Authors:  José Manuel Cameselle-Teijeiro; José Antonio Mato Mato; Ovidio Fernández Calvo; Jesús García Mata
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

9.  Midnight salivary cortisol for the diagnosis of Cushing's syndrome in a Chinese population.

Authors:  Dao-Chen Lin; Pei-Shan Tsai; Yi-Chun Lin
Journal:  Singapore Med J       Date:  2018-11-29       Impact factor: 1.858

10.  Specificity of screening tests for Cushing's syndrome in an overweight and obese population.

Authors:  Smita K Baid; Domenica Rubino; Ninet Sinaii; Sheila Ramsey; Arthur Frank; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.